UTAH MEDICAL PRODUCTS INC
For the period ended Mar 31, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 12, 2026
UTMD$72.23+1.7%Stored close · as of Nov 6, 2026
Contents
Item 1. Financial Statements
| PART I - FINANCIAL INFORMATION | ||||||
|---|---|---|---|---|---|---|
| Item 1. Financial Statements | ||||||
| UTAH MEDICAL PRODUCTS, INC. AND SUBSIDIARIES | ||||||
| CONSOLIDATED CONDENSED BALANCE SHEETS AS OF | ||||||
| MARCH 31, 2026 AND DECEMBER 31, 2025 | ||||||
| (in thousands) | ||||||
| (unaudited) · (audited) | ||||||
| MARCH 31, 2026 · DECEMBER 31, 2025 | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash & Investments | $87,406 | $85,756 | ||||
| Accounts & other receivables, net | 3,636 | 3,522 | ||||
| Inventories | 8,722 | 7,935 | ||||
| Other current assets | 614 | 529 | ||||
| Total current assets | 100,378 | 97,742 | ||||
| Property and equipment, net | 9,721 | 9,908 | ||||
| Goodwill | 13,919 | 14,052 | ||||
| Other intangible assets | 55,298 | 55,941 | ||||
| Other intangible assets - accumulated amortization | (54,934) | (55,101) | ||||
| Other intangible assets, net | 364 | 840 | ||||
| Total assets | $124,382 | $122,542 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
| Current liabilities: | ||||||
| Accounts payable | $1,194 | $911 | ||||
| Accrued expenses | 2,311 | 1,687 | ||||
| Current portion of notes payable · - · - | ||||||
| Total current liabilities | 3,505 | 2,598 | ||||
| Notes payable | - | - | ||||
| Deferred tax liability - Femcare IIA | - | 114 | ||||
| Other long term liabilities | - | - | ||||
| Long-term lease liability | 210 | 225 | ||||
| Deferred income taxes | 294 | 337 | ||||
| Total liabilities | 4,009 | 3,274 | ||||
| Stockholders' equity: | ||||||
| Common stock - $0.01 par value; authorized - 50,000 shares; issued and outstanding - March 31, 2026, 3,184 shares and December 31, 2025, 3,186 shares | 32 | 32 | ||||
| Accumulated other comprehensive loss | (9,919) | (9,416) | ||||
| Additional paid-in capital · - · - | ||||||
| Retained earnings | 130,260 | 128,652 | ||||
| Total stockholders' equity | 120,373 | 119,268 | ||||
| Total liabilities and stockholders' equity | $124,382 | $122,542 | ||||
| see notes to consolidated condensed financial statements | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.